Number | % | ||
Geographical Region (Missing data in 2 files) | Cairo Metropolitan Area | 16 | 33.3% |
Middle Egypt | 8 | 16.7% | |
Nile Delta | 22 | 45.8% | |
Upper Egypt | 2 | 4.2% | |
Age at Diagnosis (years) | ≤6 | 29 | 58.0% |
>6 | 21 | 42.0% | |
Gender | Female | 21 | 42.0% |
Male | 29 | 58.0% | |
Family History | 4 | 8.0% | |
Headache | 32 | 64.0% | |
Blurring of Vision | 10 | 20.0% | |
Vomiting | 37 | 74.0% | |
Cranial Nerve Affection | 14 | 28.0% | |
Gait Disturbance | 16 | 32.0% | |
Performance Status | 0 - 1 | 31 | 62.0% |
2 - 4 | 19 | 38.0% | |
Histologic Grade | Grade 2 | 2 | 4.0% |
Grade 3 | 2 | 4.0% | |
Grade 4 | 46 | 92.0% | |
Risk Stratification | High | 39 | 78.0% |
Standard | 11 | 22.0% | |
CSF Dissemination | 30 | 60.0% | |
M stage | M0 | 19 | 38.0% |
M1 | 22 | 44.0% | |
M2 | 2 | 4.0% | |
M3 | 7 | 14.0% | |
Type of Surgery | Total Resection | 19 | 38.0% |
Near Total Resection | 4 | 8.0% | |
Subtotal Resection | 17 | 34.0% | |
Biopsy | 10 | 20.0% | |
Post-operative Residual Disease (cm) | None | 19 | 38.0% |
≤1.5 | 4 | 8% | |
>1.5 | 27 | 54.0% | |
Received RT (CSI) | CSI 23.4 Gy/13 Fx | 13 | 26.0% |
CSI 36 Gy/20 Fx | 37 | 74.0% | |
Received RT (PF boost) | PF boost 30.6 Gy/17 Fx | 13 | 26.0% |
PF boost 18 Gy/10 Fx | 37 | 74.0% | |
RT Completion | 49 | 98.0% | |
Neoadjuvant Chemotherapy | 4 | 8.0% | |
CCRT | 47 | 94.0% | |
Adjuvant Chemotherapy | 50 | 100.0% | |
Response to Treatment | CR | 30 | 60.0% |
PR | 16 | 32.0% | |
SD | 2 | 4.0% | |
PD | 2 | 4.0% |